HPV-Related Cervical Carcinoma Clinical Trials

7 recruiting

HPV-Related Cervical Carcinoma Trials at a Glance

7 actively recruiting trials for hpv-related cervical carcinoma are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Bethesda, Bratislava, and Chicago. Lead sponsors running hpv-related cervical carcinoma studies include Christian Hinrichs, First Affiliated Hospital of Wenzhou Medical University, and BlueSky Immunotherapies GmbH.

Browse hpv-related cervical carcinoma trials by phase

Treatments under study

About HPV-Related Cervical Carcinoma Clinical Trials

Looking for clinical trials for HPV-Related Cervical Carcinoma? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new HPV-Related Cervical Carcinoma trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about HPV-Related Cervical Carcinoma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Detecting HPV DNA in Anal and Cervical Cancers

Cervical CancerAnal CancerHPV-Related Anal Squamous Cell Carcinoma+3 more
University of Chicago20 enrolled2 locationsNCT04857528
Recruiting
Phase 2

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Cervical CancerMetastatic CancerAnal Cancer+18 more
Christian Hinrichs20 enrolled3 locationsNCT05686226
Recruiting
Phase 1Phase 2

A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

HPV-Related Cervical CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma
Theravectys S.A.72 enrolled4 locationsNCT06319963
Recruiting
Phase 2

Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes

HPV-Related Anal Squamous Cell CarcinomaHPV-Related Cervical CarcinomaHPV-Related Carcinoma+2 more
Instituto do Cancer do Estado de São Paulo150 enrolled1 locationNCT06640283
Recruiting
Not Applicable

Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection

HPV-Related Cervical CarcinomaHPV InfectionLow-Grade Squamous Intraepithelial Lesions+1 more
First Affiliated Hospital of Wenzhou Medical University40 enrolled1 locationNCT06052033
Recruiting
Phase 1

Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women

HPV-Related Cervical CarcinomaHPV Infection
BlueSky Immunotherapies GmbH20 enrolled1 locationNCT05829629
Recruiting
Not Applicable

Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples

HPV-Related Cervical CarcinomaHuman Papilloma VirusUterine Cervical Neoplasm+1 more
Universiteit Antwerpen100 enrolled1 locationNCT06598176